We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
From Jul 2019 to Jul 2024
Gamesa Wind Turbines Pvt. Ltd., a unit of Spain's Gamesa Corporacion Tecnologica SA (GCTAY), one of the world's largest wind turbine makers by capacity, Tuesday received an order for 2,000 megawatts of wind power projects from India-focused Caparo Energy Ltd. (CNE.LN).
The projects will be implemented by 2016, the two companies said. They didn't disclose the value of the order.
"The agreement is part of Caparo Energy's long-term strategy to secure its supply of turbines at a preferential pricing," they said.
-By Eric Yep, Dow Jones Newswires; +91-11-4356-3305; santanu.choudhury@dowjones.com
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
